ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OABI vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

OmniAb Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: OABI 1 — JNJ 8
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OABI VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OABI JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -22.60% 25.50% -48.10 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -4.87% 2.97% -7.84 JNJ /fcf-yield <GO>
Operating Margin -60.00% 34.70% -94.70 JNJ /operating-margins <GO>
Net Profit Margin -60.00% 28.50% -88.50 JNJ /net-margins <GO>
Revenue Growth (YoY) -29.30% 6.00% -35.30 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.19 5.59 +6.60 OABI /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.7 62.1 -3.43 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $760.4M $662.49B -$661.73B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OABI REV JNJ REV OABI GROSS % JNJ GROSS % OABI FCF JNJ FCF
FY 2025 $18.7M $94.19B — 67.9% -$37.0M $19.70B
FY 2024 $26.4M $88.82B — 69.1% -$41.5M $19.84B
FY 2023 $34.2M $85.16B — — $2.3M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OABI // BETA —
JNJ // BETA 1.08